ROBINS HARLAN S
Chief Scientific Officer
ROBINS HARLAN S has filed 11 SEC Form 4 filings (20 transaction rows) across 1 company, with disclosures dating back to 2025. 11 of those filings fall inside the rolling window. Most recent filing: Jul 23, 2026.
On the most recent filing, ROBINS HARLAN S is listed as Chief Scientific Officer at Adaptive Biotechnologies Corp. Inside the rolling window, ROBINS HARLAN S reported no open-market purchases and 14 open-market sales totaling $29.6M in ADPT. The largest disclosed transaction in the window is a sale of 492,400 ADPT shares on Jul 21, 2026, worth $10.8M.
Companies traded
Other insiders at ADPT
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$29.6M
reported sales (SEC code S)
Companies
1
in the rolling window
| Source | |||||||
|---|---|---|---|---|---|---|---|
| ADPT | Chief Scientific Officer | Sale | 492,400 | $10.8M | Jul 23 | SEC ↗ | |
| ADPT | Chief Scientific Officer | Sale | 386,240 | $8.5M | Jul 7 | SEC ↗ | |
| ADPT | Chief Scientific Officer | Sale | 100,000 | $1.7M | Jun 17 | SEC ↗ | |
| ADPT | Chief Scientific Officer | Sale | 6,160 | $111K | Jun 17 | SEC ↗ | |
| ADPT | Chief Scientific Officer | Sale | 10,000 | $149K | Apr 10 | SEC ↗ | |
| ADPT | Chief Scientific Officer | Sale | 470,266 | $6.2M | Mar 13 | SEC ↗ | |
| ADPT | Chief Scientific Officer | Sale | 10,000 | $157K | Mar 4 | SEC ↗ | |
| ADPT | Chief Scientific Officer | Sale | 14,233 | $235K | Mar 4 | SEC ↗ | |
| ADPT | Chief Scientific Officer | Sale | 34,668 | $645K | Feb 4 | SEC ↗ | |
| ADPT | Chief Scientific Officer | Sale | 8,120 | $154K | Feb 4 | SEC ↗ | |
| ADPT | Chief Scientific Officer | Sale | 10,000 | $164K | Jan 8 | SEC ↗ | |
| ADPT | Chief Scientific Officer | Sale | 27,212 | $506K | Dec 5 | SEC ↗ | |
| ADPT | Chief Scientific Officer | Sale | 10,000 | $166K | Dec 5 | SEC ↗ | |
| ADPT | Chief Scientific Officer | Sale | 10,000 | $148K | Nov 12 | SEC ↗ |
Frequently asked questions
How many SEC Form 4 filings has ROBINS HARLAN S made?
ROBINS HARLAN S has filed 11 SEC Form 4 filings (20 transaction rows) across 1 company since 2025.
Which companies does ROBINS HARLAN S trade?
ROBINS HARLAN S has filed SEC Form 4 disclosures for 1 company, including ADPT.
When was ROBINS HARLAN S's most recent SEC Form 4 filing?
ROBINS HARLAN S's most recent SEC Form 4 filing on Tracefour is dated Jul 23, 2026.
What is ROBINS HARLAN S's job title?
On the most recent SEC Form 4 filings tracked by Tracefour, ROBINS HARLAN S is listed as Chief Scientific Officer.
What is ROBINS HARLAN S's total buy and sell value in the current window?
Inside the rolling retention window, ROBINS HARLAN S bought $0 and sold $29.6M based on SEC Form 4 filings.
What was ROBINS HARLAN S's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 492,400 ADPT shares on 2026-07-21, worth $10.8M, per SEC Form 4 filings.